| Q91850724 | 2013 Banff Criteria for Acute Antibody-Mediated Rejection Are Superior to 2007 Banff Criteria in the Diagnosis and Assessment of Renal Allograft Outcomes |
| Q37720377 | Antibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft Injury |
| Q38169496 | Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms. |
| Q52586350 | Clinical Utility of Complement-Dependent C3d Assay in Kidney Recipients Presenting with Late Allograft Dysfunction. |
| Q47574733 | Clinical and histopathologic features of antibody-mediated rejection among pediatric renal transplant recipients with preformed vs de novo donor-specific antibodies |
| Q34427661 | Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions |
| Q94588711 | Flow cytometry crossmatching to investigate kidney-biopsy-proven, antibody-mediated rejection in patients who develop de novo donor-specific antibodies |
| Q37590820 | From Humoral Theory to Performant Risk Stratification in Kidney Transplantation. |
| Q36417907 | IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury |
| Q35648701 | Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection |
| Q85930818 | Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results |
| Q36173541 | Rational clinical trial design for antibody mediated renal allograft injury. |
| Q34289498 | Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation |
| Q33407913 | Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy |
| Q35790552 | Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts |
| Q26862195 | The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection |
| Q53307803 | The prognostic significance of glomerular infiltrating leukocytes during acute renal allograft rejection. |
| Q38247690 | The significance of histological diagnosis in renal allograft biopsies in 2014. |
| Q38151921 | The specificity of acute and chronic microvascular alterations in renal allografts |
| Q40634986 | Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss |